| pubmed-article:18048817 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18048817 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:18048817 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:18048817 | lifeskim:mentions | umls-concept:C0007112 | lld:lifeskim |
| pubmed-article:18048817 | lifeskim:mentions | umls-concept:C0030797 | lld:lifeskim |
| pubmed-article:18048817 | lifeskim:mentions | umls-concept:C0392752 | lld:lifeskim |
| pubmed-article:18048817 | lifeskim:mentions | umls-concept:C1548161 | lld:lifeskim |
| pubmed-article:18048817 | pubmed:issue | 34 | lld:pubmed |
| pubmed-article:18048817 | pubmed:dateCreated | 2007-11-30 | lld:pubmed |
| pubmed-article:18048817 | pubmed:abstractText | To assess the benefit and toxicity and quality-of-life (QOL) outcomes of pelvic nodes irradiation in nonmetastatic prostate carcinoma patients. | lld:pubmed |
| pubmed-article:18048817 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18048817 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18048817 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18048817 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18048817 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18048817 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18048817 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:PommierPascal... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:CarrieChristi... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:ChabaudSylvie... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:VoirinNicolas... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:RichaudPierre... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:PerolDavidD | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:Le... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:LesaunierFran... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:LagrangeJean... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:WagnerJean... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:HayMeng... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:BeckendorfVer... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:SuchaudJean... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:Pabot du... | lld:pubmed |
| pubmed-article:18048817 | pubmed:author | pubmed-author:BernierValeri... | lld:pubmed |
| pubmed-article:18048817 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18048817 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:18048817 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:18048817 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18048817 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18048817 | pubmed:pagination | 5366-73 | lld:pubmed |
| pubmed-article:18048817 | pubmed:dateRevised | 2008-4-29 | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:meshHeading | pubmed-meshheading:18048817... | lld:pubmed |
| pubmed-article:18048817 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:18048817 | pubmed:articleTitle | Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01. | lld:pubmed |
| pubmed-article:18048817 | pubmed:affiliation | Centre Léon Bérard, Department of Radiotherapy, Lyon, France. pommier@lyon.fnclcc.fr | lld:pubmed |
| pubmed-article:18048817 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18048817 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18048817 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18048817 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:18048817 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18048817 | lld:pubmed |
